Patients can develop dehydration rather quickly while taking these medications"
Dual GIP/GLP-1 receptor agonists , like tirzepatide, take this one step further
"For pharmaceutical executives, the lesson is clear: success in obesity will depend not only on science but also on vigilance, payer alignment, cultural reframing, and equitable access." The Evolution of Obesity Drugs: Lessons from a Century of Failures and the GLP-1 Breakthrough Thani Jambulingam, PhD The arrival of GLP-1 receptor agonists and dual agonists has delivered unprecedented efficacy, reframed obesity as a chronic disease, and sparked an industry gold rush
The initial wave of excitement has now settled into a complex reality of access, affordability, and a sprawling, often confusing market
If there are toddlers under 3 years old at home, abdominal tenderness prevents the mother from bending over to pick up a 30lb child
It functions as a triple receptor agonist at the GIP, GLP-1, and glucagon receptors